Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI)

Historical Holders from Q3 2021 to Q3 2025

Symbol
RANI on Nasdaq
Type / Class
Equity / Class A Common Stock, $0.0001 par value per share
Shares outstanding
99.8M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
4.03M
Holdings value
$2.02M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
36
Number of buys
13
Number of sells
-13
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
InCube Labs, L.L.C. 22.1% $13.5M 27.1M MIR A IMRAN 23 Oct 2025
Samsara BioCapital, L.P. 9.9% $4.94M 9.88M Srinivas Akkaraju 23 Oct 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% $4.94M 9.88M RA Capital Management, L.P. 23 Oct 2025
Invus Global Management, LLC 9.99% $4.91M 9.83M Raymond Debbane 16 Oct 2025
ARMISTICE CAPITAL, LLC 9.91% $4.13M 6.26M Armistice Capital, LLC 30 Jun 2025
South Cone Investments Limited Partnership 4.9% $1.19M 2.38M South Cone Investments Limited Partnership 20 Oct 2025
Orca Capital AG 4.3% -56% $972K -$1.27M 1.89M -56.6% Orca Capital AG 22 Jul 2025

Institutional Holders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 4.03M $2.02M -$1.26M $0.50 36
2025 Q2 6.46M $3.32M +$1.06M $0.51 38
2025 Q1 3.61M $4.58M -$333K $1.26 38
2024 Q4 3.82M $5.23M -$4.95M $1.37 42
2024 Q3 5.91M $12.8M +$6M $2.16 31
2024 Q2 3.11M $11.8M -$1.25M $3.80 33
2024 Q1 3.45M $10.7M +$509K $3.11 35
2023 Q4 3.29M $10.9M -$820K $3.32 33
2023 Q3 3.21M $6.96M -$152K $2.18 32
2023 Q2 3.23M $13.3M +$994K $4.12 34
2023 Q1 3M $15.5M +$205K $5.16 35
2022 Q4 2.89M $17M -$1.47M $5.90 32
2022 Q3 3.17M $30.4M +$3.58M $9.58 30
2022 Q2 2.82M $29.1M +$2.77M $10.33 27
2022 Q1 2.56M $34.5M +$17.6M $13.50 23
2021 Q4 1.24M $20.3M +$544K $16.35 21
2021 Q3 1.1M $19.6M +$19.6M $17.82 14